1 / 1

Nontuberculous Mycobacterial (NTM) Infections Market

The total prevalent population of Nontuberculous Mycobacteria Infection in 7MM is expected to be 3,95,429 by 2030. The United States accounts for approximately 49% of the total prevalent population in 7MM. The therapeutic market of Nontuberculous Mycobacteria Infection in 7MM is expected to grow at a CAGR of 6.6% during the study period. The key players in the Nontuberculous Mycobacteria Infection market include Insmed Inc., RedHill Biopharma, Novoteris, Savara Inc, Beyond Air and others. <br>For more information visit: <br>https://www.delveinsight.com/report-store/nontuberculous-mycobacterial-ntm-infections-market<br><br><br><br>

DelveInsight
Download Presentation

Nontuberculous Mycobacterial (NTM) Infections Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related